SUMMARY Reverse triiodothyronine (rT3), triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH) values were measured by radioimmunoassay in 40 children with congenital hypothyroidism who were being given levothyroxine (0.05-0*35 mg/day) and in 14 normal controls. The serum T3 and T4 concentrations were estimated using kits prepared by BARC (Bhabha Atomic Research Centre), India. The minimal detectable value for T3 was 0-125 ng/ml and for T4 was 1.2 ng/ml. Quality control was maintained by using pooled serum dispensed in small vials and preserved at -20°C: one of these was assayed with every batch. The tests and standards were run in duplicate. The interassay percent coefficient of variation was 10.9 for T3 and 7.9 for T4. rT3 was estimated by radioimmunoassay (RIA) (code 1834 Hypolab A A Coinsins, Switzerland). The RIA kit contained a quality control test, and the sensitivity of the assay was 0-06 ng/ml. The TSH was estimated by RIA using the double antibody technique of Midglay. Reagents were kindly supplied by the National Institute of Health, Bethesda, USA. The sensitivity of the TSH assay system was 1 ,uU/ml. 
In the past the adequacy of thyroid replacement treatment was judged by clinical and radiological criteria. We undertook to evaluate the efficacy of these criteria by estimating thyroid hormone and thyroid stimulating hormone (TSH) values; serum reverse triiodothyronine (rT3) was also estimated. This report forms part of a study on 66 hypothyroid children in which we showed that unusually large doses of levothyroxine (L-T4) were used.' In 40 patients rT3 values were available and we analyse the data and the probable importance of rT3 in children receiving replacement treatment.
Material and methods
Serum triiodothyronine (T3), thyroxine (T4), TSH, and rT3 were estimated in 40 children with congenital hypothyroidism who were receiving regular replacement treatment and in 14 normal controls.
The children were aged between 1 and 14 years. Diagnosis had been established by the usual clinical and laboratory criteria. The hypothyroid children included here had received L-T4 in doses ranging from 0 1-0 35 mg/day over a period varying from 12 months-12 years. A body weight based dose schedule was not used. Periodic clinical evaluation, anthropometric assessmrent, and bone age determination (Greulich and Pyle standard) were available for all children.
The serum T3 and T4 concentrations were estimated using kits prepared by BARC (Bhabha Atomic Research Centre), India. The minimal detectable value for T3 was 0-125 ng/ml and for T4 was 1.2 ng/ml. Quality control was maintained by using pooled serum dispensed in small vials and preserved at -20°C: one of these was assayed with every batch. The tests and standards were run in duplicate. The interassay percent coefficient of variation was 10.9 for T3 and 7.9 for T4. rT3 was estimated by radioimmunoassay (RIA) (code 1834 Hypolab A A Coinsins, Switzerland). The RIA kit contained a quality control test, and the sensitivity of the assay was 0-06 ng/ml. The TSH was estimated by RIA The T3 value in the overtreated group, mean SD 1 53 (0-76) ng/ml (2.34 (1.17) nmol/l) was not significantly different from the controls or adequately treated children (P>0.05). In 4 of the overtreated children the serum T3 values exceeded the upper normal limit, with values ranging from 2 5-4 ng/ml (3-84-6 14 nmol/l) (Fig. 1) .
The rT3 value, mean (SD) 0-737 (0.366) ng/ml (1.13 (0 56) nmol/l) in the overtreated group was significantly higher than in the control group and in children on adequate treatment (P<0.01) ( Table 1) . The mean rT3 :T4 ratio in the overtreated group was also significantly higher compared with controls and adequately treated children (P<0.01).
Fifteen hypothyroid children who could be classified as adequately treated had serum T3 and T4 values of mean (SD) 1 19 (0 54) ng/ml (1 83 (0.83) nmol/l) and 108 (12-9) ng/ml (140.26 (16.75) nmol/l) respectively (Table 1) . Their TSH values ranged from 3-8 [±U/ml. In five of this group, in whom the serum T4 was between 120 and 130 ng/ml (156 and 169 nmol/l) after intravenous TRH, TSH rose from a basal value of 3-5 ,uU/ml to between 12 and 20 ,uU/ml at 30 minutes. This response confirmed that the L-T4 doses were adequate. The rT3 value of these 15 children was, mean (SD) 0.265 (0.078) ng/ml (0-41 (0.12) nmol/l) and the rT3:T4 ratio was, mean (SD) 0*0026 (0.0008); similar to the values obtaining in control children (Table 1) .
In four of the children with raised serum T4 and rT3 values, the L-T4 doses were reduced and hormone estimations were repeated. The resultant reduction in the serum T4 values was accompanied by a simultaneous decline in rT3 concentrations (Fig. 2) .
The lack of overt clinical hyperthyroidism among these 25 overtreated hypothyroid children with raised T4 concentrations was of interest. Fifty percent had no symptoms or signs. Normal range L. rT3=009 -035ng/ml, T3=0 7-2ng/ml, T4=50-130ng/ml In hypothyroid patients on thyroid replacement treatment the basic peripheral mechanisms for metabolic deiodination of T4 to T3 and rT3 are intact. 2 7 This is shown by the simultaneous increase in both these fractions along with serum T4 when thyroxine treatmrent is begun. In a recent study in hypothyroid adults with progressive increments in the dosage of thyroxine, a simultaneous increase in serum T4, T3, rT3 and the rT3 :T4 ratio was described.'1 Changes in the concentrations of serum T3 and rT3 were noted with starvation in patients whose thyroid function was suppressed by giving exogenous T4. '2 Some important findings have come from our study. In the adequately treated group the serum values of T4, T3, rT3, and the rT3 :T4 ratio were all within normal limits, but the mean serum rT3 value was considerably raised and the rT3:T4 ratio was appreciably higher in children receiving excessive doses of L-T4. A reciprocal relation often exists between T3 and rT3, but in our study the relation was analogous to endogenous T4 thyrotoxicosis where rT3, T4, and T3 are raised. We suggest that the activation of bcdy homeostatic mechanisms that result in the production of larger amounts of rT3 protect most children with hypothyroidism from iatrogenically induced hyperthyroidism by shunting peripheral T4 metabolism from an activating to an inactivating pathway. As 
